Nanotechnology, Nanomedicine, and AI: Toward the Dream of Global Health Care Equivalency
“Progress in medicine, global access to information and a global age pyramid that is already turning upside-down will increase the demand for good health care. This in turn will increase life expectancy and drive innovation. This re-enforcing circle will change societies’ views on health care. Whereas today it is seen as a cost that needs to be controlled — which slows down progress — it might become the global driving force of innovation and humanity, replacing other areas of public investment focus.”
Harald Stock, President & CEO, ArjoHuntleigh
We are very fortunate indeed to be living at a time where the speed of advances in medical technologies is such that we can expect to live increasingly healthier and longer lives; far beyond what would ever have been imagined as possible only a century ago. However, in contrast to our natural inalienable human rights to life, liberty, and the pursuit of happiness, our equally important right to good health (and by extension good health care), which is critical for all of us, is unfortunately either in disarray, dysfunctional, or completely neglected on a global scale.
The State of Health Care Today
A news item released on December 2017, by the World Health Organization (WHO) entitled: “World Bank and WHO: Half the world lacks access to essential health services, 100 million still pushed into extreme poverty because of health expenses”, reported that “800 million people spend at least 10 percent of their household budgets on health expenses for themselves, a sick child or other family member. For almost 100 million people these expenses are high enough to push them into extreme poverty, forcing them to survive on just $1.90 or less a day.” A 2017 report authored by Dr. Margaret Chan (Director-General, WHO) stated that “Nearly 2 billion people have no access to basic medicines, causing a cascade of preventable misery and suffering.” The current state of affairs in the developed world for those who are fortunate enough to have access to medical care, in some cases includes the burden of $1000 per dose, and from $100,000 to $1.21 million per year in individual drug expenditures alone.
What is Global Health Care Equivalency (GHCE)?
Looking ahead over the next 10-30 years, with the rapid emergence of, and synergies between, the disciplines of nanotechnology, nanomedicine, and AI, we can envisage a future world where any individual on the planet has access to the same advanced and cost effective nanomedical diagnostic and therapeutic technologies, no matter how wealthy or impoverished they are, no matter where they happen to reside, or under what conditions they live. Progress toward this goal will be incremental, with each successive wave of nanomedical technologies being more advanced than the previous wave. The tipping point will arrive with the emergence of Molecular Manufacturing (MM), http://ieet.org/index.php/IEET/more/boehm20160115, which will make possible the cost effective fabrication of the classes of advanced autonomous nanomedical devices that Boehm describes in his first book: Nanomedical Device and Systems Design: Challenges, Possibilities, Visions. A situation may then well arise where the entire human population will finally come to realize the inalienable human right of optimal health for life through the establishment of a worldwide health care system under the moniker: “Global Health Care Equivalency” (GHCE). The details and vision for GHCE will be articulated in an upcoming book: Nanotechnology, Nanomedicine, and AI: Toward the Dream of Global Health Care Equivalency that is currently being generated by the originator of this concept (Frank Boehm – CEO of NanoApps Medical Incorporated) in collaboration with numerous thought leading authors.
Perceived Benefits of GHCE
The attainment of GHCE might serve to significantly reduce the perception of individuals in the developing world of being marginalized, at least in terms of health care, which may ultimately translate to conflict reduction. In the developed world, GHCE would serve to dramatically reduce health care expenditures across the board. Progress toward this goal will be incremental, with each successive wave of nanomedical technologies being more advanced than the previous wave. The tipping point will arrive with the emergence of Molecular Manufacturing (MM), http://ieet.org/index.php/IEET/more/boehm20160115, which will make possible the cost effective fabrication of the types of advanced autonomous nanomedical devices that Boehm describes in his first book: Nanomedical Device and Systems Design: Challenges, Possibilities, Visions.
It is worth noting here that all nations on a global scale stand to benefit immensely when their citizens are healthy, as they would save hundreds of millions, if not billions of dollars in health-related expenditures, not to mention lost work hours and overall productivity, due to illness and its associated incapacities.
The core essence of GHCE is aptly conveyed in the thought below:
“In a world facing considerable uncertainty, international health development is a unifying – and uplifting – force for the good of humanity.”
Dr Chan, WHO Director-General
What is Molecular Manufacturing (MM)
The first mention of the possibility of MM emerged through the words of Dr. Richard Feynman in 1959, via his famous talk, “Plenty of Room at the Bottom”, where he spoke of the possibility of the controlled manipulation of matter at the atomic level. Dr. Eric Drexler described the remarkable capabilities that he envisioned for a conceptual molecular assembler in his 1986 book, Engines of Creation. In 2003, Chris Phoenix generated a paper that articulated the Design of a Primitive Nanofactory. Dr. Robert Freitas Jr. et al., have extensively investigated Diamond MechanoSynthesis and personalized Nanofactories from 2002 to the present.
Once MM is developed, it will have the capacity to fabricate just about any consumer item or food, as well as advanced autonomous nanomedical robots from elemental atoms and molecules, guided by AI-driven specifications. By virtue of these fundamental feed stocks, it will likely become very cost effective to fabricate (physician prescribed) nanomedical devices to address virtually any condition that ails us, in one’s own home, via Factory@Home (F@H) units, which might be manifest as countertop microwave-sized appliances that are extensively distributed worldwide. Concurrently, home based atomic and molecular “disassembly” units would be able to completely recycle, sort, and repackage practically any type of material according to its specific atomic and molecular species, which could again be used to supply the F@H units for fabrication.
Awaking the Dream
Although the attainment of GHCE would indeed be a truly extraordinary achievement, we must keenly recognize that in reality, such a massive undertaking on a global scale will require intense and sustained high spirited collaboration between like minded individuals who have widely varied backgrounds within diverse areas of expertise. Highly specialized laboratories, dynamic administrative institutions, regulatory bodies, and government agencies worldwide will also be vital prerequisites for its realization, as will significant resources and time. We are all amazing individuals, each with our own unique talents and expertise that might contribute and be applied to this noble enterprise. Our working together might culminate in a positive critical mass on a global scale toward the actual realization of GHCE, which would ultimately be of benefit for each and every one of us, as we are finally “all” supported in our natural human right of optimal health for life.
It is the question scientists around the world are trying to answer: how long can the coronavirus survive in the tiny aerosol particles we exhale? In a high-security lab near Bristol, entered through a series [...]
As the COVID-19 pandemic rages on, researchers are working overtime to develop vaccines and therapies to thwart SARS-CoV-2, the virus responsible for the disease Many efforts focus on the coronavirus spike protein, which binds the [...]
A research team in Hungary pinched the coronavirus with a fine needle to measure how much force it could take before popping like a balloon. It did not. The native virion of Sars-CoV-2 – a [...]
Headaches, confusion and delirium experienced by some Covid-19 patients could be the result of the coronavirus directly invading the brain, according to a study published Wednesday. The research is still preliminary – but offers several [...]
By Boris M | Published in Coronavirus During the COVID-19 pandemic, there will be a lot of information about the virus and its effects on mental health. That’s because coronavirus and the social, financial and psychological [...]
A serious illness suffered by an Oxford University coronavirus vaccine trial participant was most likely “life-threatening”, a bioethics researcher says. But that doesn’t mean the clinical trials will be scrapped. AstraZeneca and Oxford University [...]
Analysis of seven trials finds dexamethasone and hydrocortisone should be given in severe cases. Studies around the world have confirmed that steroids can save lives in the Covid-19 pandemic, leading to new recommendations from [...]
Experts say strong evidence of efficacy needed to avoid approval of inferior vaccines. The rush to immunise populations against Covid-19 could lead to the rollout of a vaccine that is not very effective and [...]
The COVID-19 pandemic has dominated the news cycle for the better part of 2020. As guidelines are continually updated to reflect changes in our understanding of how the virus spreads, it is critical people [...]
Scientists in Hong Kong have reported the first confirmed case of reinfection with the coronavirus that causes Covid-19, reportedly backed up by genetic sequences of the two episodes of the 33-year-old man’s infections in March and [...]
Could uncomfortable nasal swabs be swapped for a contactless two-second breathalyzer puff to check for Covid-19 infection? Prof. Hossam Haick thinks so. Haick, a professor of chemical engineering and nanotechnology at the Technion – [...]
The relationship between antibodies for the novel coronavirus (SARS-CoV-2) and immunity, vaccine efficacy, and spread of COVID-19 has received significant attention. Dr. Seheult is back to illustrate why T cells have received less [...]
Images Description Three individuals were admitted to the hospital (ages 46–56; to men and one woman) with a multiday history of symptoms associated with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and underwent [...]